During the past decade, U.O. Complessa di Ematologia Ospedale di Parma conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "U.O. Complessa di Ematologia Ospedale di Parma" #1 collaborator was "Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte" with 1 trials as a collaborator, "Janssen Pharmaceutica" with 1 trials as a collaborator and "Janssen-Cilag Ltd." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "U.O. Complessa di Ematologia Ospedale di Parma" are "Diffuse Large B-Cell" (1 trials), "Diffuse Large B-cell Lymphoma Recurrent" (1 trials), "Diffuse Large B-cell Lymphoma Refractory" (1 trials), "Follicular Lymphoma Grade 3A" (1 trials) and "Follicular Lymphoma, Grade 1" (1 trials). Many other conditions were trialed in "U.O. Complessa di Ematologia Ospedale di Parma" in a lesser frequency.

Most popular intervention types in "U.O. Complessa di Ematologia Ospedale di Parma" are "Drug" (5 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "BEAM" (1 trials), "BR-DHAP" (1 trials), "Bendamustine, Lenalidomide, Rituximab" (1 trials), "OFATUMUMAB" (1 trials) and "R-CHOP with doxorubicin" (1 trials). Other intervention names were less common.

The vast majority of trials in "U.O. Complessa di Ematologia Ospedale di Parma" are 5 trials for "All" genders.

Currently, there are NaN active trials in "U.O. Complessa di Ematologia Ospedale di Parma". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in U.O. Complessa di Ematologia Ospedale di Parma, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in U.O. Complessa di Ematologia Ospedale di Parma, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".